Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongzi Liu

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Heliyon|August 28, 2023
SARS-CoV-2 genomic characterization and evolution in ChinaPeng Zhang, Dongzi Liu, Lei Ji, et al.
Molecular Therapy. Nucleic Acids|January 22, 2026
Engineered CRISPR-Cas13a system with enhanced target RNA cleavage activity and reduced collateral activity for therapeutic applicationsWenxia Zhang, Haili Wang, Dongzi Liu, et al.
International Journal of Biological Macromolecules|May 31, 2026
enCas7-11S3: A compact Cas7-11 variant with enhanced RNA cleavage and minimal collateral activityHaili Wang, Wenxia Zhang, Dongzi Liu, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Heliyon|August 28, 2023
SARS-CoV-2 genomic characterization and evolution in ChinaPeng Zhang, Dongzi Liu, Lei Ji, et al.
Molecular Therapy. Nucleic Acids|January 22, 2026
Engineered CRISPR-Cas13a system with enhanced target RNA cleavage activity and reduced collateral activity for therapeutic applicationsWenxia Zhang, Haili Wang, Dongzi Liu, et al.
International Journal of Biological Macromolecules|May 31, 2026
enCas7-11S3: A compact Cas7-11 variant with enhanced RNA cleavage and minimal collateral activityHaili Wang, Wenxia Zhang, Dongzi Liu, et al.
Pageof 1